Skip to main content
Premium Trial:

Request an Annual Quote

Xoma to Supply Antibody Agents to SRI International for NIAID Study

NEW YORK (GenomeWeb News) — Xoma today said it will create monoclonal antibody agents for SRI International as part of that company’s deal with the National Institute of Allergy and Infectious Disease.
 
Xoma said the firms are still negotiating their contract, which will span 5 years and could be worth as much as $28.1 million. The company added that, if the full contract is awarded it will bring to $60 million the total amount of government contracts it has received since 2005.
 
Additional details were not disclosed.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.